PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PM vs. ABBV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between PM and ABBV is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

PM vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Philip Morris International Inc. (PM) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%AugustSeptemberOctoberNovemberDecember2025
11.87%
-0.52%
PM
ABBV

Key characteristics

Sharpe Ratio

PM:

1.51

ABBV:

0.39

Sortino Ratio

PM:

2.32

ABBV:

0.64

Omega Ratio

PM:

1.31

ABBV:

1.10

Calmar Ratio

PM:

2.66

ABBV:

0.49

Martin Ratio

PM:

8.40

ABBV:

1.23

Ulcer Index

PM:

3.64%

ABBV:

7.61%

Daily Std Dev

PM:

20.31%

ABBV:

23.74%

Max Drawdown

PM:

-42.87%

ABBV:

-45.09%

Current Drawdown

PM:

-9.95%

ABBV:

-15.16%

Fundamentals

Market Cap

PM:

$184.26B

ABBV:

$302.80B

EPS

PM:

$6.30

ABBV:

$2.86

PE Ratio

PM:

18.81

ABBV:

59.91

PEG Ratio

PM:

1.47

ABBV:

0.40

Total Revenue (TTM)

PM:

$28.11B

ABBV:

$41.23B

Gross Profit (TTM)

PM:

$18.01B

ABBV:

$30.76B

EBITDA (TTM)

PM:

$11.66B

ABBV:

$17.62B

Returns By Period

In the year-to-date period, PM achieves a -1.53% return, which is significantly higher than ABBV's -2.66% return. Over the past 10 years, PM has underperformed ABBV with an annualized return of 9.12%, while ABBV has yielded a comparatively higher 14.98% annualized return.


PM

YTD

-1.53%

1M

-4.85%

6M

11.87%

1Y

31.68%

5Y*

11.92%

10Y*

9.12%

ABBV

YTD

-2.66%

1M

0.78%

6M

-0.52%

1Y

9.98%

5Y*

19.25%

10Y*

14.98%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PM vs. ABBV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PM
The Risk-Adjusted Performance Rank of PM is 8989
Overall Rank
The Sharpe Ratio Rank of PM is 8888
Sharpe Ratio Rank
The Sortino Ratio Rank of PM is 8686
Sortino Ratio Rank
The Omega Ratio Rank of PM is 8686
Omega Ratio Rank
The Calmar Ratio Rank of PM is 9494
Calmar Ratio Rank
The Martin Ratio Rank of PM is 9090
Martin Ratio Rank

ABBV
The Risk-Adjusted Performance Rank of ABBV is 6161
Overall Rank
The Sharpe Ratio Rank of ABBV is 6464
Sharpe Ratio Rank
The Sortino Ratio Rank of ABBV is 5353
Sortino Ratio Rank
The Omega Ratio Rank of ABBV is 5656
Omega Ratio Rank
The Calmar Ratio Rank of ABBV is 6969
Calmar Ratio Rank
The Martin Ratio Rank of ABBV is 6363
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PM vs. ABBV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Philip Morris International Inc. (PM) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for PM, currently valued at 1.51, compared to the broader market-2.000.002.001.510.39
The chart of Sortino ratio for PM, currently valued at 2.32, compared to the broader market-4.00-2.000.002.004.002.320.64
The chart of Omega ratio for PM, currently valued at 1.31, compared to the broader market0.501.001.502.001.311.10
The chart of Calmar ratio for PM, currently valued at 2.66, compared to the broader market0.002.004.006.002.660.49
The chart of Martin ratio for PM, currently valued at 8.40, compared to the broader market-30.00-20.00-10.000.0010.0020.008.401.23
PM
ABBV

The current PM Sharpe Ratio is 1.51, which is higher than the ABBV Sharpe Ratio of 0.39. The chart below compares the historical Sharpe Ratios of PM and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.501.001.502.002.503.00AugustSeptemberOctoberNovemberDecember2025
1.51
0.39
PM
ABBV

Dividends

PM vs. ABBV - Dividend Comparison

PM's dividend yield for the trailing twelve months is around 4.47%, more than ABBV's 3.67% yield.


TTM20242023202220212020201920182017201620152014
PM
Philip Morris International Inc.
4.47%4.40%5.46%4.98%5.16%5.73%5.43%6.73%3.99%4.50%4.60%4.76%
ABBV
AbbVie Inc.
3.67%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%

Drawdowns

PM vs. ABBV - Drawdown Comparison

The maximum PM drawdown since its inception was -42.87%, roughly equal to the maximum ABBV drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for PM and ABBV. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-9.95%
-15.16%
PM
ABBV

Volatility

PM vs. ABBV - Volatility Comparison

Philip Morris International Inc. (PM) and AbbVie Inc. (ABBV) have volatilities of 5.33% and 5.54%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%AugustSeptemberOctoberNovemberDecember2025
5.33%
5.54%
PM
ABBV

Financials

PM vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between Philip Morris International Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab